{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:05:22Z","timestamp":1791201922379,"version":"4.2.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1093\/sleep\/33.2.169","type":"journal-article","created":{"date-parts":[[2017,2,5]],"date-time":"2017-02-05T15:27:34Z","timestamp":1486308454000},"page":"169-176","source":"Crossref","is-referenced-by-count":85,"title":["Validation of the ICSD-2 Criteria for CSF Hypocretin-1 Measurements in the Diagnosis of Narcolepsy in the Danish Population"],"prefix":"10.1093","volume":"33","author":[{"given":"Stine","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul J.","family":"Jennum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u2205rgen","family":"Alving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u2205ren","family":"Paludan Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"Gammeltoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t20170420032813_B1","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","year":"2000","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170420032813_B2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","year":"2000","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170420032813_B3","volume-title":"International classification of sleep disorders, 2nd \u00e9d.: diagnostic and coding manual","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"key\n\t\t\t\t20170420032813_B4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/sleep\/30.8.969","article-title":"CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway","volume":"30","year":"2007","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B5","first-page":"361","article-title":"[Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia]","volume":"128","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"key\n\t\t\t\t20170420032813_B6","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions","volume":"74","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170420032813_B7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3346\/jkms.2007.22.1.127","article-title":"Lee SP HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy.","volume":"22","year":"2007","journal-title":"J Korean Med Sci"},{"key":"key\n\t\t\t\t20170420032813_B8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1474-4422(08)70140-6","article-title":"CSF hypocretin-1 assessment in sleep and neurological disorders","volume":"7","year":"2008","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170420032813_B9","first-page":"77","article-title":"Validation of a cataplexy questionnaire in 983 sleep-disorders patients","volume":"22","year":"1999","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"Anew method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","year":"1991","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/1352458508088939","article-title":"Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis","volume":"14","year":"2008","journal-title":"Mult Scler"},{"key":"key\n\t\t\t\t20170420032813_B12","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","year":"2002","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170420032813_B13","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1212\/01.WNL.0000147328.15956.B4","article-title":"CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders","volume":"63","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170420032813_B14","first-page":"402","article-title":"Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy","volume":"77","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170420032813_B15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.0962-1105.2003.00373.x","article-title":"CSF hypocretin measures in patients with obstructive sleep apnea","volume":"12","year":"2003","journal-title":"J Sleep Res"},{"key":"key\n\t\t\t\t20170420032813_B16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mds.21965","article-title":"Cataplexy features in childhood narcolepsy","volume":"23","year":"2008","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170420032813_B17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/sleep\/29.11.1439","article-title":"Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1\/orexin-A findings","volume":"29","year":"2006","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/sleep\/30.1.27","article-title":"Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy","volume":"30","year":"2007","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2869.2002.00284.x","article-title":"CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia","volume":"11","year":"2002","journal-title":"J Sleep Res"},{"key":"key\n\t\t\t\t20170420032813_B20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/sleep\/26.5.555","article-title":"Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children","volume":"26","year":"2003","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2002-23601","article-title":"Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy","volume":"33","year":"2002","journal-title":"Neuropediatrics"},{"key":"key\n\t\t\t\t20170420032813_B22","first-page":"440","article-title":"HLA and hypocretin studies in Korean patients with narcolepsy","volume":"25","year":"2002","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/sleep\/29.11.1429","article-title":"Astudy of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness","volume":"29","year":"2006","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/sleep\/29.8.1017","article-title":"CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?","volume":"29","year":"2006","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170420032813_B26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy","volume":"50","year":"2001","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170420032813_B27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.WNL.0000101718.92619.67","article-title":"Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis","volume":"62","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170420032813_B28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.02.010","article-title":"Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy","volume":"174","year":"2006","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170420032813_B29","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","year":"2001","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170420032813_B30","first-page":"411","article-title":"Human leukocyte antigen and narcolepsy: present status and relationship with familial history and hypocretin deficiency","volume-title":"Narcolepsy and hypersomnia","year":"2007"},{"key":"key\n\t\t\t\t20170420032813_B31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/s1389-9457(02)00191-0","article-title":"The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A)","volume":"4","year":"2003","journal-title":"Sleep Med"},{"key":"key\n\t\t\t\t20170420032813_B32","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","article-title":"Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease","volume":"130","year":"2007","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170420032813_B33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","year":"2005","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170420032813_B34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.20892","article-title":"Follow-up of four narcolepsy patients treated with intravenous immunoglobulins.","volume":"60","year":"2006","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170420032813_B35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy","volume":"12","year":"2003","journal-title":"J Sleep Res"},{"key":"key\n\t\t\t\t20170420032813_B36","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","year":"1997","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20170420032813_B37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000079749","article-title":"Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness","volume":"52","year":"2004","journal-title":"Eur Neurol"},{"key":"key\n\t\t\t\t20170420032813_B38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/01.WNL.0000081049.14098.50","article-title":"CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies","volume":"61","year":"2003","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170420032813_B39","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1212\/WNL.62.12.2337","article-title":"CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies","volume":"62","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170420032813_B40","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awl079","article-title":"Correlates of sleep-onset REM periods during the multiple sleep latency test in community adults","volume":"129","year":"2006","journal-title":"Brain"}],"container-title":["Sleep"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/sleep\/article-pdf\/33\/2\/169\/13664898\/sleep-33-2-169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T08:39:21Z","timestamp":1568795961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article-lookup\/doi\/10.1093\/sleep\/33.2.169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/33.2.169","relation":{},"ISSN":["1550-9109","0161-8105"],"issn-type":[{"value":"1550-9109","type":"electronic"},{"value":"0161-8105","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}